You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 20, 10 NOVEMBER 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cost-effectiveness of Noninvasive Diagnostic Aids in Suspected Pulmonary Embolism

Arnaud Perrier, MD; Lorenz Buswell, MD; Henri Bounameaux, MD; Dominique Didier, MD; Alfredo Morabia, MD; Philippe de Moerloose, MD; Daniel Slosman, MD; Pierre-F. Unger, MD; Alain Junod, MD

Arch Intern Med. 1997;157(20):2309-2316.


Abstract

Background
Noninvasive instruments such as plasma D-dimer measurement (DD) and lower-limb compression ultrasonogaphy (US) are being increasingly advocated to reduce the number of necessary angiograms in patients having suspected pulmonary embolism (PE) and a nondiagnostic lung scan. We therefore designed a decision analysis model (1) to evaluate the cost-effectiveness of combining these noninvasive diagnostic aids with lung scan and angiography in the diagnosis of PE and (2) to determine the optimal sequence and combination of tests taking into account the clinical probability of PE.

Methods
We performed a cost-effectiveness analysis based on literature data, including data from a management study in our institution. Six diagnostic strategies were compared with the reference, ie, lung scan followed when nondiagnostic (low or intermediate probability) by angiography. In all strategies, PE was ruled out by a normal or near-normal scan, a negative DD (plasma level below 500 µg/L), or a negative angiogram. Pulmonary embolism was diagnosed and anticoagulant treatment was undertaken in the presence of a high-probability lung scan, deep vein thrombosis showed by US, or a positive angiogram. In case of a nondiagnostic scan (low or intermediate probability), patients could be either treated or not treated, or undergo other tests, according to the selected strategy.

Results
Under baseline conditions (prevalence of PE, 35%), strategies combining DD and US with lung scan, angiography being done only in case of an inconclusive noninvasive workup (DD level >500 µg/L, normal US, and nondiagnostic lung scan), were most cost-effective. This approach yielded a 9% incremental cost reduction and a 37% to 47% decrease in the number of necessary angiograms compared with the reference strategy (scan±angiography). For patients with a low clinical probability of PE (≤20%), withholding treatment from those with a low-probability lung scan without performing an angiogram proved safe and highly cost-effective (30% cost reduction), provided US showed no deep vein thrombosis.

Conclusion
The DD test and US are cost-effective in the diagnostic workup of PE, whether performed after or before lung scan, thus allowing centers devoid of lung scanning and/or angiography facilities to screen patients with suspected PE and avoid costly referrals. In patients with a low clinical probability, a low-probability lung scan, and a normal US, treatment may be withheld without resorting to angiography.

Arch Intern Med. 1997;157:2309-2316



Author Affiliations

From the Medical Clinic 1 (Drs Perrier, Buswell, and Junod) and Divisions of Angiology and Hemostasis (Drs Bounameaux and de Moerloose), Radiodiagnosis (Dr Didier), Clinical Epidemiology (Dr Morabia), Nuclear Medicine (Dr Slosman), and Medical and Surgical Emergency (Dr Unger), Geneva University Hospital, Geneva, Switzerland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cost-effectiveness of Ultrasound in Preventing Femoral Venous Catheter-associated Pulmonary Embolism
Cox et al.
Am. J. Respir. Crit. Care Med. 2003;168:1481-1487.
ABSTRACT | FULL TEXT  

Transthoracic Sonography of the Lung and Pleura in View of a Suspected Pulmonary Embolism: A Pilot Study
Mohn et al.
J Ultrasound Med 2003;22:673-678.
ABSTRACT | FULL TEXT  

Role of fibrin D-dimer testing in emergency medicine
Wakai et al.
Emerg. Med. J. 2003;20:319-325.
ABSTRACT | FULL TEXT  

Cost-Effectiveness Analysis of Diagnostic Strategies for Suspected Pulmonary Embolism Including Helical Computed Tomography
Perrier et al.
Am. J. Respir. Crit. Care Med. 2003;167:39-44.
ABSTRACT | FULL TEXT  

The Impact of the Introduction of a Rapid D-Dimer Assay on the Diagnostic Evaluation of Suspected Pulmonary Embolism
Goldstein et al.
Arch Intern Med 2001;161:567-571.
ABSTRACT | FULL TEXT  

Guidelines on diagnosis and management of acute pulmonary embolism
Eur Heart J 2000;21:1301-1336.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.